Page last updated: 2024-11-06

n-butoxyacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-Butoxyacetic acid, also known as butyric acid, is a colorless liquid with a characteristic odor. It is a carboxylic acid and is used as a solvent, plasticizer, and intermediate in the production of various chemicals. The compound is generally synthesized through the reaction of n-butanol with chloroacetic acid. While its effects on human health are not extensively studied, it is considered a mild irritant to the skin and eyes. Research into n-butoxyacetic acid focuses on its potential use in various industrial applications, including its use in the production of polymers, resins, and other organic chemicals. Its biodegradability and environmental impact are also areas of ongoing study.'

n-butoxyacetic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID41958
CHEBI ID173542
SCHEMBL ID24207
MeSH IDM0067553

Synonyms (30)

Synonym
CHEBI:173542
2516-93-0
nsc-10980
nsc10980
nsc 10980
butoxyacetic acid
acetic acid, butoxy-
ccris 7195
n-butoxyacetic acid
2-butoxyacetic acid
B1467 ,
FT-0694874
inchi=1/c6h12o3/c1-2-3-4-9-5-6(7)8/h2-5h2,1h3,(h,7,8)
ajqoasgwdcbkcj-uhfffaoysa-
EN300-80606
AKOS005287767
acetic acid, 2-butoxy-
SCHEMBL24207
mfcd00067044
SY002472
3-oxaheptanoic acid
DTXSID0050392
n-butoxyacetic acid, aldrichcpr
J-015848
Q22137005
AC1559
CS-11012
n-butoxyaceticacid
CS-0152080
Z409190912

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Ethylene glycol mono-n-alkyl ethers are a major class of industrial chemicals which cause a wide range of toxic effects in laboratory animals including reproductive and developmental toxicity, as well as hematotoxicity."( Structure-activity relationships for the in vitro hematotoxicity of N-alkoxyacetic acids, the toxic metabolites of glycol ethers.
Burka, LT; Ghanayem, BI; Matthews, HB, 1989
)
0.28

Pharmacokinetics

ExcerptReferenceRelevance
"A physiologically based pharmacokinetic model was developed to describe the disposition of 2-butoxyethanol (CAS 111-76-2) and its major metabolite, 2-butoxyacetic acid, in rats and humans."( Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans.
Bormett, GA; Corley, RA; Ghanayem, BI, 1994
)
0.29
"A physiologically based pharmacokinetic (PBPK) model describing the disposition of 2-butoxyethanol (2-BE) was developed in order to predict the urinary concentration of its major metabolite, butoxyacetic acid (BAA) under a range of exposure scenarios."( Physiologically based pharmacokinetic modelling of human exposure to 2-butoxyethanol.
Cocker, J; Franks, SJ; Loizou, GD; Spendiff, MK, 2006
)
0.33

Bioavailability

ExcerptReferenceRelevance
" The model explained the change of profiles of urinary metabolites in different exposure routes by taking into account the differences in absorption rate and by incorporating a minor pathway for metabolism by skin."( Physiologically based modeling of 2-butoxyethanol disposition in rats following different routes of exposure.
Birnbaum, LS; Henderson, RF; Medinsky, MA; Sabourin, PJ; Shyr, LJ, 1993
)
0.29

Dosage Studied

ExcerptRelevanceReference
" In this study effects on red blood cell morphology of dosing rats with 2-BE by gavage were compared with the effects of incubation of rat erythrocytes in vitro with the principal metabolite of 2-BE, butoxyacetic acid (BAA)."( Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: a comparison with the in vitro effects of butoxyacetic acid on rat and human erythrocytes.
Udden, MM,
)
0.13
" The dose-response relationship between BAA concentration and hemolysis determined in the presence or absence of calcium showed an increased effect of BAA in the absence of calcium."( Butoxyacetic acid-induced hemolysis of rat red blood cells: effect of external osmolarity and cations.
Patton, CS; Udden, MM, 2005
)
0.33
" The skin surface was dosed with 115."( Metabolism of butoxyethanol in excised human skin in vitro.
Traynor, MJ; Wilkinson, SC; Williams, FM, 2008
)
0.35
" For developmental toxicity this requires scaling the in vitro observed dose-response characteristics to in vivo fetal exposure, while integrating maternal in vivo kinetics during pregnancy, in particular transplacental transfer."( Integrating in vitro chemical transplacental passage into a generic PBK model: A QIVIVE approach.
Fragki, S; Hoogenveen, R; Piersma, AH; Schwillens, P; van Oostrom, C; Zeilmaker, MJ, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carboxylic acidA carbon oxoacid acid carrying at least one -C(=O)OH group and having the structure RC(=O)OH, where R is any any monovalent functional group. Carboxylic acids are the most common type of organic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (17.07)18.7374
1990's13 (31.71)18.2507
2000's17 (41.46)29.6817
2010's3 (7.32)24.3611
2020's1 (2.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.89 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.13%)5.53%
Reviews1 (2.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (95.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]